Inside the EIC Summit 2026 exhibition: 22 awardee projects and what to look for in Brussels
- ›The EIC Summit 2026 exhibition will showcase 22 EIC-backed projects on 3–4 June at Tour and Taxis in Brussels.
- ›Technologies span green hydrogen, quantum, AI, wave energy, advanced materials, medtech and space infrastructure.
- ›Several exhibitors link to recent EIC Pathfinder, Transition and Accelerator grants, but most claims still require validation in real-world use.
- ›The exhibition area also hosts EIC Business Acceleration Services, five international partner booths and an EU initiatives zone.
- ›Registrations are open via the EIC Summit page.
What the exhibition is and why it matters
The European Innovation Council Summit 2026 will take place on 3–4 June at Tour and Taxis in Brussels. At the centre of the event is the exhibition area, where 22 EIC-backed projects across all EIC funding schemes will present prototypes, research outputs and commercialization plans. The line-up ranges from green hydrogen and quantum hardware to bionic prosthetics, sustainable construction, space infrastructure and value-aware artificial intelligence. The exhibition is designed as a meeting place for investors, corporates, researchers and policymakers to evaluate technology readiness, match with potential partners and stress test commercial narratives.
Who is exhibiting
Below is a consolidated view of the 22 projects slated for the exhibition, with their stated focus and country of the exhibiting team. Several have public CORDIS records detailing grant IDs, coordinators and timelines, which are noted separately further down.
| Project | Country | Focus at the exhibition | Notable claim or context |
| 3DPrintOptixMarket | Greece | 3D‑printed micro‑lenses and micro‑optics for mixed reality | Targeting high quality at lower cost for MR optics manufacturing |
| ANEMEL | Ireland | Green hydrogen from saline and waste waters | Alternative feedstocks to reduce freshwater use |
| Argo Semiconductors (Argo Active Antenna) | Greece | Active antenna platform | Exhibitor states 25% lower cost and power for satellite radio terminals |
| Axiles Bionics | Belgium | AI‑powered bionic foot for lower‑limb amputations | Restores more natural gait via embedded control and biomechanics |
| CHARM | Italy | Cancer digital histopathology | Label‑free molecular characterisation of tumours |
| CM4Cure (Coati‑X) | Belgium | Bioactive coating for catheters and blood‑contact devices | Dual prevention of thrombosis and bloodstream infections; developed with FRESCI |
| CorPower Ocean (CorPack) | Sweden | High‑efficiency wave energy technology | Storm‑survivable WEC, modular CorPack clusters for wave farms |
| ECaBox | Spain | Ex vivo perfusion of pig and human donor eyes | Maintains near‑physiological conditions for ophthalmic R&D |
| Elobio | France | Low‑temperature electrolysers using biomass feedstocks | Co‑production of hydrogen and value‑added chemicals |
| EnduroSat | Bulgaria | Space infrastructure builder for high‑performance satellites | End‑to‑end smallsat platforms and services |
| Equal1 (Quenml) | Ireland | Silicon‑based quantum computing | UnityQ hybrid quantum‑classical silicon‑on‑chip in a rack‑mount server |
| FlowBeams (iSENS) | Netherlands | Needle‑free injection and sensing via laser‑driven microfluidics | Painless micro‑jet injections with real‑time monitoring |
| HEALANT (SHINTO) | Belgium | Solid self‑healing material platform | Soft robotics and recyclable polymers from VUB research |
| Hyperion Robotics (3Dgeocarbon) | Finland | Carbon‑negative construction technology | Automated, material‑efficient concrete alternatives |
| Mi‑Hy | Belgium | Mini‑SPIKA building core for wastewater‑to‑energy | Bacteriophage‑inspired core produces energy and biofertiliser |
| RAW | Denmark | Resource‑aware AEC model using waste‑sourced bio‑materials | Computational design embracing material variability |
| Releaf Paper | France | Circular fibres and biocomposites from urban green waste | Packaging and consumer goods feedstocks |
| Scienta Lab (PRISM) | France | Multimodal foundation model for immunology | AI to improve preclinical efficacy prediction |
| SMACool | Germany | Elastocaloric air‑conditioning for households | Solid‑state refrigerants aim for 2–3x efficiency gains |
| Sparrow Quantum (QTool) | Denmark | Light‑matter interfaces for optical quantum tech | Single‑photon sources rooted in Niels Bohr Institute research |
| UroPrint | Greece | Laser printing of immunocompatible urothelial tissue | Ex vivo and in vivo printing for bladder augmentation |
| VALAWAI | Spain | Value‑aware AI systems | Embedding value frameworks and explainability into AI |
Technical concepts you will encounter, explained
Context from recent EIC and EU project records
Several exhibitors are tied to grants recorded on CORDIS, offering insight on funding instruments, timelines and stated objectives. Coordinating entities may differ from the exhibiting company’s country listed above, reflecting consortia or corporate structures.
| Project | Grant ID | Scheme | Dates | Coordinator (CORDIS) |
| 3DPRINTOPTIXMARKET | 101113140 | EIC Transition Open 2022 | Jun 2023 – May 2026 | PRINTOPTIX GmbH, Germany |
| ELOBIO | 101070856 | EIC Pathfinder Challenges 2021 | Jan 2023 – Dec 2026 | CNRS, France |
| HEALANT (SHINTO) | 101057960 | EIC Transition Open 2021 | Oct 2022 – Sep 2025 | Vrije Universiteit Brussel, Belgium |
| Coati‑X | 101158575 | EIC Transition Open 2023 | Apr 2024 – Mar 2027 | CM4Cure SA, Belgium |
| iSENS | 101158591 | EIC Transition Open 2023 | Jul 2024 – Jun 2027 | FlowBeams BV, Netherlands |
| RAW | 101161441 | EIC Pathfinder Challenges 2023 | Nov 2024 – Oct 2027 | Royal Danish Academy, Denmark |
| SMACool | 101162223 | EIC Pathfinder Challenges 2023 | Oct 2024 – Sep 2027 | Universität des Saarlandes, Germany |
| Argo Active Antenna | 101188086 | EIC Accelerator Open 2024 | Dec 2024 – Nov 2026 | Argo IMIAGOGOI AE, Greece |
| CorPack | 101218387 | EIC Accelerator Challenges 2024 | Jul 2025 – Jun 2027 | CorPower Ocean AB, Sweden |
| PRISM | 101247838 | EIC Accelerator Open 2025 | Dec 2025 – Nov 2027 | Scienta Lab, France |
| QUENML | 190105118 | EIC Accelerator Blended Finance 2021 | Jun 2022 – Dec 2024 | Equal1 Laboratories, Ireland |
| EnduroSat InnoSpaceComm | 768049 | H2020 SME Instrument Phase 2 | Jun 2017 – Feb 2019 | ENDUROSAT AD, Bulgaria |
| ECaBox | 964342 | H2020 FET Open | Sep 2021 – Aug 2025 | Centre for Genomic Regulation, Spain |
| UroPrint | 964883 | H2020 FET Open | Sep 2021 – Aug 2025 | Biomedical Research Foundation of the Academy of Athens, Greece |
| VALAWAI | 101070930 | EIC Pathfinder Challenges 2021 | Oct 2022 – Sep 2026 | CSIC, Spain |
These records help situate the exhibition: some teams are advancing lab concepts toward pilots, others are tailoring business models or seeking first customers. They also indicate where independent outcomes will appear next, for instance through deliverables, publications or eventual regulatory filings.
Signals, strengths and caveats across the line‑up
Energy systems and decarbonisation
Projects such as ANEMEL, Elobio, CorPower Ocean and SMACool all target hard problems in the energy transition. Biomass‑assisted electrolysis could lower energy intensity for hydrogen while co‑producing chemicals, but hinges on feedstock sustainability and electrocatalyst selectivity. Wave energy has long struggled with survivability and cost. CorPower’s approach promises storm‑mode resilience and higher power capture yet it still faces bankability and project finance hurdles that only utility‑scale deployments will resolve. Elastocaloric cooling is attractive on paper due to efficiency and zero GWP refrigerants, but durability of alloys, manufacturing costs and noise or vibration profiles in domestic settings must be validated.
Medtech and bioengineering
FlowBeams’ needle‑free injection targets practical pain points from needle phobia to medical waste. The platform’s sensing and real‑time monitoring are differentiators, though device certification, consumables cost and training will shape adoption. CM4Cure’s dual‑action catheter coating addresses hospital‑acquired infection and thrombosis but will traverse a long preclinical and clinical path, with scaling challenges in consistent drug loading and release profiles. ECaBox and UroPrint exemplify ex vivo and biofabrication advances that could reduce translational failure in ophthalmology and urology, yet regulatory and ethical frameworks around tissue sourcing, and the leap from feasibility to routine clinical use, remain non‑trivial.
Quantum and advanced computing
Equal1 and Sparrow Quantum represent hardware‑centric bets. Equal1’s silicon‑based hybrid system aims for tighter classical‑quantum integration. Claims of large qubit arrays and AI acceleration deserve careful third‑party benchmarking and clarity on error rates and usable logical qubits. Sparrow Quantum’s single‑photon and light‑matter interface work ties into optical quantum networks and sensors where reliability and source indistinguishability are central metrics.
Materials, manufacturing and construction
HEALANT’s self‑healing polymers and Hyperion’s automated, lower‑carbon construction feed the EU’s push for circularity. The SHINTO transition project points to recyclability and extended product lifetimes in soft robotics. RAW proposes a new computation‑driven resource model for AEC that embraces variability in bio‑based materials rather than fighting it. Beyond lab pilots, insurers, building codes and supply chains will determine whether these reach mainstream construction. 3DPrintOptixMarket’s micro‑optics target MR’s long‑standing cost and form‑factor constraints, with the usual scale‑up questions around yield, metrology and process control.
Space and communications
EnduroSat’s infrastructure pitch aligns with continued demand for integrated smallsat services. Argo Semiconductors’ active antenna work, as described in EIC records, focuses on sub‑6 GHz 5G radio units with integrated RFICs and printed antenna arrays to reduce cost and power. Exhibitor materials also refer to satellite terminal improvements. Either way, network performance claims should be weighed against deployment scenarios, thermal constraints and total cost of ownership for operators.
AI, data and trust
Scienta Lab’s PRISM model for immunology targets the costly attrition in inflammation trials. Success will depend on high‑quality multimodal datasets, clear validation protocols and acceptance by regulators and pharma partners. VALAWAI’s value‑aware AI toolbox is aligned with Europe’s emphasis on trustworthy AI. Sociotechnical evaluation and integration with product development lifecycles will be as important as algorithmic novelty.
What visitors will find in the exhibition area
The exhibition will run across both days of the Summit. Beyond the 22 project stands, the floor will host the EIC Business Acceleration Services stand, a dedicated EU initiatives area with free support services and funding opportunities for innovators, and five international partner booths.
| Exhibition component | What it offers | Notes |
| Project stands | Direct contact with teams, prototypes, demos | All EIC schemes represented |
| EIC BAS stand | Information on services beyond funding | Matchmaking, investment readiness and growth tools |
| International partner booths | Organisations from Canada, Japan, Singapore, South Korea, United Arab Emirates | Entry points to non‑EU markets |
| EU initiatives area | EU bodies, initiatives and projects | Free support services and funding information |
Planning and registration
The exhibition is open throughout 3–4 June, allowing time to engage with teams and explore collaborations. Registrations for the EIC Summit 2026 are open via the event page. The EIC Business Acceleration Services will also be present with complementary activities and matchmaking alongside the exhibition area. Check the official programme and session pages for updates and registration details. Note that some satellite activities managed by BAS may require separate sign‑up.
How to assess claims on the floor
Disclosure
Information on exhibitors and exhibition features is based on EIC Community communications for the Summit and publicly available CORDIS records. It is provided for knowledge sharing and should not be interpreted as the official view of the European Commission or any other organisation.

